Pono Capital Corp (PONO) to Combine with Benuvia in $440M Deal
Warning: DOMDocument::loadHTML(): Unexpected end tag : p in Entity, line: 5 in /var/convesio/wordpress/wp-content/plugins/spacinsider-upqode/src/Start.php on line 90
Pono (NYSE:PONO) has entered into a definitive agreement to acquire Benuvia, Inc., a drug developer focused on pharmaceutical cannabinoids, at an enterprise value of $440 million. The Arizona-based company owns an FDA approved cannabinoid drug SYNDROS (dronabinol oral solution CII), and synthetic cannabinoid manufacturing facilities in the U.S. The combined company is expected to trade
Read More